The Effect of Palmitoylethanolamide on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers—A Randomized, Double-Blinded, Placebo-Controlled Crossover Trial

Palmitoylethanolamide (PEA) is marketed as a “dietary food for special medical purposes”. Its broad-spectrum analgesic, anti-inflammatory, and neuroprotective effects make PEA an interesting substance in pain management. However, the underlying analgetic mechanisms have not yet been investigated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang-Illievich, Kordula, Klivinyi, Christoph, Rumpold-Seitlinger, Gudrun, Dorn, Christian, Bornemann-Cimenti, Helmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570726/
https://www.ncbi.nlm.nih.gov/pubmed/36235736
http://dx.doi.org/10.3390/nu14194084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570726/
https://www.ncbi.nlm.nih.gov/pubmed/36235736
http://dx.doi.org/10.3390/nu14194084

Ejemplares similares